{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2018", "item": "https://www.patentleaderboard.com/2018/"}, {"@type": "ListItem", "position": 3, "name": "Pfizer", "item": "https://www.patentleaderboard.com/2018/company/pfizer"}, {"@type": "ListItem", "position": 4, "name": "Simone Sciabola", "item": "https://www.patentleaderboard.com/2018/inventor/fl:si_ln:sciabola-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SS

Simone Sciabola — 2 Patents in 2018

Pfizer: 2 patents #26 of 317Top 9%
Cambridge, MA: #236 of 1,336 inventorsTop 20%
Massachusetts: #2,224 of 12,682 inventorsTop 20%
Overall (2018): #101,830 of 503,207Top 25%
2 Patents 2018

Issued Patents 2018

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
10131669 Pyrazolopyrimidine compounds Thomas Allen Chappie, Patrick Robert Verhoest, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal +3 more 2018-11-20 $851,493,000
10077269 Imidazopyridazine compounds Thomas Allen Chappie, Nandini Chaturbhai Patel, Matthew Merrill Hayward, Christopher John Helal, Erik Alphie LaChapelle +2 more 2018-09-18 $396,134,000